"Klinikum Rheine
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dickgreber, Nicolas
TIE, NCT00678964 / 2005-005827-32: Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Recruiting
2
260
Europe
Erlotinib, Tarceva, Vinorelbine and Carboplatin, Navelbine, Carboplat
Hospital Grosshansdorf
Non-Small Cell Lung Cancer
11/08
 
NCT03345810 / 2016-003963-20: Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

Checkmark Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial.
Checkmark Durvalumab in frail and older patients with stage IV non-small cell lung cancer: the randomized phase II DURATION trial
Recruiting
2
200
Europe
Durvalumab, MEDI4736, Vinorelbine, Gemcitabine, nab-Paclitaxel, Abraxane, Carboplatin
AIO-Studien-gGmbH, AstraZeneca, Celgene
Carcinoma, Non-Small-Cell Lung, Metastatic Lung Cancer, Non Small Cell Lung Cancer, Lung Adenocarcinoma Metastatic, Large Cell Lung Carcinoma Metastatic
06/22
12/22

Download Options